Qure.AI Sets Sights on IPO in Two Years as AI Transforms Indian Healthcare Landscape

Qure.AI, India's healthcare AI startup providing early diagnosis solutions for tuberculosis, lung cancer, and stroke risk, plans to become profitable in the next fiscal year and list with an IPO in two to two-and-a-half years, CEO Prashant Warier told Reuters in an interview. Founded in 2016 by investors including Peak XV Partners and Novo Holdings, Qure.AI has already raised $125 million and was valued at $264 million as of November 2024.

 

The firm sees about 15 million patients annually, and its revenue source comes from 25% in the United States, which is its biggest market. It is also growing in Latin America and Africa, specifically in the low- and middle-income nations. Qure.AI has a 60%-70% annual revenue growth rate, driven by increasing AI use in healthcare to detect diseases early and ease clinicians' workload.

 

Source: Reuters, Economic Times